يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Okpara, Chinyere E"', وقت الاستعلام: 0.81s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.

    المؤلفون: Grünwald, Viktor, Powles, Thomas, Masatoshi Eto, Kopyltsov, Evgeny, Sun Young Rha, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., José Méndez-Vidal, María, Sung-Hoo Hong, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Tomas, Toshio Takagi, Burgents, Joseph E., Perini, Rodolfo, Cixin He, Okpara, Chinyere E., McKenzie, Jodi

    المصدر: Frontiers in Oncology; 2024, p1-10, 10p

    مصطلحات موضوعية: SUNITINIB, RENAL cell carcinoma, BONE metastasis, THERAPEUTICS, TREATMENT effectiveness, PROGRESSION-free survival

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms

    المؤلفون: Grünwald, Viktor, Powles, Thomas, Eto, Masatoshi, Kopyltsov, Evgeny, Rha, Sun Young, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., Méndez-Vidal, María José, Hong, Sung-Hoo, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Tomas, Takagi, Toshio, Burgents, Joseph E., Perini, Rodolfo, He, Cixin, Okpara, Chinyere E., McKenzie, Jodi, Choueiri, Toni K.

    المساهمون: Grünwald, Viktor, Powles, Thoma, Eto, Masatoshi, Kopyltsov, Evgeny, Rha, Sun Young, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., Méndez-Vidal, María José, Hong, Sung-Hoo, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Toma, Takagi, Toshio, Burgents, Joseph E., Perini, Rodolfo, He, Cixin, Okpara, Chinyere E., Mckenzie, Jodi, Choueiri, Toni K.

    مصطلحات موضوعية: bone metastase, lenvatinib, liver metastase, lung metastase, pembrolizumab, renal cell carcinoma, sarcomatoid histology, sunitinib

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37664025; info:eu-repo/semantics/altIdentifier/wos/WOS:001059317200001; volume:13; firstpage:1223282; journal:FRONTIERS IN ONCOLOGY; https://hdl.handle.net/11586/464767Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85169664916

    الإتاحة: https://doi.org/10.3389/fonc.2023.1223282Test
    https://hdl.handle.net/11586/464767Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.

    المؤلفون: Grünwald, Viktor, Powles, Thomas, Masatoshi Eto, Kopyltsov, Evgeny, Sun Young Rha, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., Méndez-Vidal, María José, Sung-Hoo Hong, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Tomas, Takagi, Toshio, Burgents, Joseph E., Perini, Rodolfo, Cixin He, Okpara, Chinyere E., McKenzie, Jodi

    المصدر: Frontiers in Oncology; 2024, p1-2, 2p

    مصطلحات موضوعية: RENAL cell carcinoma, SUNITINIB, MEDICAL sciences

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies.

    المؤلفون: Motzer, Robert J., Taylor, Matthew H., Evans, Thomas R. Jeffry, Okusaka, Takuji, Glen, Hilary, Lubiniecki, Gregory M., Dutcus, Corina, Smith, Alan D., Okpara, Chinyere E., Hussein, Ziad, Hayato, Seiichi, Tamai, Toshiyuki, Makker, Vicky

    المصدر: Expert Review of Anticancer Therapy; Ap2022, Vol. 22 Issue 4, p383-400, 18p

    مصطلحات موضوعية: THYROID cancer, RENAL cell carcinoma, PROTEIN-tyrosine kinase inhibitors, ENDOMETRIAL cancer, HEPATOCELLULAR carcinoma, ANTINEOPLASTIC agents


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث